This federal contract award, valued at $1,267.04, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,690,189 units of the prescription medication Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024.
The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This specific delivery order is for the supply of the prescription drug Tamsulosin, which is commonly used to treat benign prostatic hyperplasia.
The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.
Generated 3/12/25, 9:49 AM